INIS
brucella
100%
mice
50%
macrophages
33%
spleen
26%
pathogens
26%
growth
26%
host
25%
genes
24%
tuberculosis
22%
rods
20%
oligosaccharides
20%
trypanosoma
20%
interferon
20%
nanoparticles
20%
drugs
20%
decarboxylase
20%
zones
20%
morphology
20%
shape
20%
control
15%
lungs
14%
mutants
12%
mycobacterium tuberculosis
11%
phosphodiesterases
10%
virulence
9%
humans
8%
comparative evaluations
8%
populations
8%
strains
8%
skin
8%
synthesis
6%
carriers
5%
secretion
5%
enzymes
5%
nose
5%
cell division
5%
regulations
5%
cell cycle
5%
mutations
5%
growth factors
5%
asymmetry
5%
Immunology and Microbiology
Brucella
70%
Mouse
60%
Brucella Melitensis
28%
Brucella Abortus
24%
Macrophage
20%
Alveolar Macrophage
20%
Trypanosoma
20%
C57BL 6 Mouse
20%
Host-Pathogen Interaction
20%
Proteobacteria
20%
Infectious Agent
20%
Rhizobiales
20%
Wild Type
18%
Mouse Model
13%
T-Helper Cell
13%
Zoonotic
10%
Growth Factor
10%
Cell Division
10%
Cell Line
10%
Zoonosis
10%
Cell Cycle Regulation
10%
Orthology
10%
Caulobacter Vibrioides
10%
Sinorhizobium meliloti
10%
Type IV Secretion System
10%
T Cell
10%
Immunosuppressive Drug
8%
Bacterial Count
6%
Mammary Gland
6%
Neutrophil Granulocyte
5%
B Cell
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Phagocyte
5%
Fatty Acid Metabolism
5%
Wild Type Mouse
5%
Purine Synthesis
5%
Deletion Mutant
5%
Mucosal Immune System
5%
Mitochondrion
5%
Fibroblast
5%
Cytokine
5%
Transposon
5%
Interleukin
5%
Operon
5%
Type Strain
5%
Binding Site
5%
Cell Level
5%
Metabolite
5%
RNA Sequence
5%
Myeloid
5%
Keyphrases
Polycyclodextrin
20%
Drug Nanocarrier
20%
Shape Morphology
20%
Marginal Zone Macrophages
20%
T. Brucei
20%
Acod1
20%
Decarboxylase
20%
Cis-aconitate
20%
Itaconate
16%
Metallophilic Macrophages
12%
Macrophage Populations
12%
Cyclodextrin Nanoparticles
10%
Intranasal
10%
Intradermal Infection
10%
Dimethyl Itaconate
8%
Methionine Transport
6%
Tryptophan Metabolism
6%
Pulmonary Infection
6%
Optimal Growth
6%
Tn-seq
6%
Lung Condition
6%
Asthmatic Mice
6%
Bacterial Morphology
5%
Asymmetric Growth
5%
Bacterial Virulence
5%
Skin Tissue
5%
CD140a
5%
Intranasal Route
5%
Infectious Reservoir
5%
Intraperitoneal Infection
5%
Ly6G
5%
Intradermal Route
5%
Live Attenuated Vaccine
5%
Intraperitoneal Route
5%
Pathogen Persistence
5%
Rational Development
5%
Vacuolar Trafficking
5%
